Dr. Rahul Kushwah reports

PREDICTMEDIX ANNOUNCES TECHNOLOGY DEPLOYMENT AT LONG TERM CARE RESIDENCE IN EDMONTON, IN PARTNERSHIP WITH OPTIMA LIVING

Predictmedix Inc. has deployed Safe Entry Stations at the Aster Garden Optima Living Community in partnership with Optima Living, Connectus Global and Juiceworks Exhibits. This marks the market entry into the long-term care and assisted living sectors in North America, which have been hit hard during the current pandemic.

A new, innovative, seniors living community offering independent living and memory care, Aster Gardens started safely welcoming residents on the first day of Spring, March 21. Karen Fitzgerald, Aster Gardens General Manager, said the scanner is one more safeguard that has been put in place to keep residents and others safe from COVID-19 as well as other infectious diseases or viruses.

"At Aster Gardens, we're extremely pleased to use such ground-breaking technology and lead the way for other seniors' communities that might consider using it," said Ali Shivji, Principal of Optima Living. "Optima Living's focus is always on creating quality, meaningful lives for residents who live in any of our 18 seniors living communities in western Canada."

"Connectus welcomes the opportunity to be involved in this project with Aster Gardens and working with a sector that has been particularly affected by the COVID-19 pandemic, to make Aster Gardens a safe place for residents to live and for families eventually to be together again. We need to take care of each other now more than ever," said Norine Anderson, COO Connectus Global.

"We're extremely proud to partner with Optima living and are excited to enter the long-term patient care market. Our AI-powered suite of technology will ensure safer living standards for all members and we are particularly proud to have taken the first step in catering to a safer, more secure community building for patients," said Dr. Rahul Kushwah, COO, Predictmedix.

About Predictmedix Inc.

Predictmedix Inc. is an artificial intelligence ("AI") company developing disruptive tools for impairment testing and healthcare. It is intended that the Company's cannabis and alcohol impairment detection tools will be used across various workplaces and by law enforcement agents. Its technology uses artificial intelligence to identify both cannabis and alcohol impairment by utilizing multiple features along with numerous different data points. Testing does not require any body fluids or human intervention, thereby helping to remove human error and the potential for discrimination and prejudice.

The Company is also developing AI based screening for the healthcare industry. The recent advent of COVID-19 pandemic has placed unprecedented stress on the global economy and highlights the need for tools to help screen mass populations for infectious diseases, with the hope of preventing pandemics in the future. In turn, Predictmedix Inc. has expanded its proprietary AI technology to screen for infectious disease symptoms.

Additionally, psychiatric disorders such as depression, dementia and Alzheimer's disease can carry a significant burden and early identification is the key to better management. To help address this, the Company is also expanding its proprietary AI technology to screen for psychiatric and/or brain disorders such as depression, dementia and Alzheimer's disease. To find out more visit us at www.predictmedix.com Disclaimer: "The Company is not making any express or implied claims that its product has the ability to diagnose, eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time." For further information, please contact: Ehsan Agahi, Investor Relations

We seek Safe Harbor.